CTOs on the Move

FibroGen

www.fibrogen.com

 
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.fibrogen.com
  • 409 Illinois St
    San Francisco, CA USA 94158
  • Phone: 415.978.1200

Executives

Name Title Contact Details
Curtis Golston
Director IT Operations Profile

Funding

FibroGen raised $126.02M on 07/09/2016

Similar Companies

Global Healthcare Public Foundation Inc

Global Healthcare Public Foundation Inc is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elite CEU

Elite CEU, Inc. is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedRep Surgical Inc

MedRep Surgical Inc is a Minnesota, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hallman Group

Hallman Group is a Kalamazoo, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cohera Medical

Cohera Medical, Inc. is a rapidly growing medical device company actively developing surgical adhesives and sealants. TissuGlu Surgical Adhesive, the first synthetic adhesive approved for internal use, is an easily applied biocompatible, resorbable adhesive that requires no mixing or thawing. Indicated for the approximation of tissue layers where subcutaneous dead space exists between tissue planes in abdominoplasty, TissuGlu Surgical Adhesive has been shown to eliminate the need for postoperative surgical drains in most abdominoplasty procedures.